National Pharmaceutical Association (NPhA)

Pharmacists spot diabetes risk early, explain heart- and kidney-protecting meds, decode CGM data, and find affordable support.

Pharmacists can build trust in buprenorphine care, handle early refill red flags, and point patients to resources to help them with substance use disorder.

Harm reduction for pharmacists can include person-first language and stigma-free naloxone counseling that keeps patients with substance use disorder safer.

Many patients struggle with the everyday realities of staying on the medication, which can include uncomfortable adverse effects.

The SUPPORT Act 2025 lets pharmacists prescribe buprenorphine for opioid use disorder, but DEA training and state rules shape access and new formulations.

Pharmacists spot subtle abuse and sexual health red flags, avoid profiling, and respond safely with resources while protecting HIPAA privacy.

Many states are pushing pharmacies to move beyond the traditional dispensing role into more robust clinical care.

From proposed transparency rules to Medicare price negotiation programs, the stakes are high for pharmacy reimbursement and the sustainability of independent practices.

As respiratory virus season approaches, misinformation threatens lives; understanding vaccines is crucial for protecting our communities and future.

To celebrate National Pharmacist Day, regonized every year on January 12, Meagan Brown, PharmD, BCACP, discussed the current state of nationally recognizing pharmacists as clinical providers.

In part 3, Meagan Brown, PharmD, BCACP, explored sentiments of pharmacist’s provider status among other health care professionals.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

Meagan Brown, PharmD, BCACP, discusses her career journey in various pharmacy roles during National Pharmacist Day, January 12.

In a recap of his recent NPhA continuing pharmacy education presentation, Kenric B. Ware, PharmD, MBA, AAHIVP, discussed pharmacists’ role in addressing HIV stigma.

In part 3 of our interview with Kenric B. Ware, PharmD, MBA, AAHIVP, he discusses the best approaches for addressing HIV care and prevention stigma.

Kenric B. Ware, PharmD, MBA, AAHIVP, addresses the pharmacist’s role in addressing HIV stigma and providing public health services for patients with the virus.

Kenric B. Ware, PharmD, MBA, AAHIVP, presents persistently common stigmas in HIV care and prevention from a recent NPhA webinar.

Shantel Upshaw Houston, PharmD, inspires pharmacy professionals to transform systemic challenges into collaborative solutions, emphasizing empathy, equity, and community engagement for meaningful change.